NCT05358626View on ClinicalTrials.gov

Seroprevalence of Infection-induced SARS-CoV-2 Antibodies (COVID-19) in Children

CompletedOBSERVATIONAL
Enrollment

4,032

Participants

Timeline

Start Date

March 13, 2022

Primary Completion Date

June 5, 2022

Study Completion Date

November 13, 2022

Conditions
COVID-19
Interventions
DIAGNOSTIC_TEST

SARS-CoV-2 IgG Antibody testing

IgG Antibody testing for previous exposure to SARS-CoV-2

Trial Locations (1)

Unknown

Vietnam National Children's Hospital, Hanoi

All Listed Sponsors
lead

National Children's Hospital, Vietnam

OTHER